Breast CA Medical Risk Reduction: USPSTF Sept 2019 Guidelines

16:22
 
Share
 

Manage episode 242377324 series 2280622
By Dr. Chapa’s ObGyn Pearls.. Discovered by Player FM and our community — copyright is owned by the publisher, not Player FM, and audio is streamed directly from their servers. Hit the Subscribe button to track updates in Player FM, or paste the feed URL into other podcast apps.
In Sept 2019, the USPTF revised and updated its 2013 recommendations on medications for risk reduction of primary breast cancer. Who qualifies for medical strategies? Which meds are recommended? In this session we will highlight the new USPSTF Guidelines, review the use of Prediction Models, and compare Tamoxifen, Raloxifene, and Aromatase Inhibitors. --- This episode is sponsored by · Techathlon Podcast: The Techathlon podcast is a weekly podcast that catches you up on the latest tech news through games, trivia, and (usually) friendly competitions. https://open.spotify.com/show/1HRe3KlPaYUVgs1zTcsztO?si=7f0rYgqhQ5WUmFbpwdKXZw · Anchor: The easiest way to make a podcast. https://anchor.fm/app

249 episodes